ArticleDigestive diseases and sciences2025

Comment on "Switching to Subcutaneous Infliximab Maintenance Therapy is Effective in Patients with Inflammatory Bowel Disease".

Joaquín Borrás-Blasco et al.PubMed ↗Publisher ↗

No numbers read from the abstract.